|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207.70 SEK | +2.16% |
|
-0.14% | -5.07% |
| 07-09 | Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively | FW |
| 07-09 | Fourth AP Fund cuts stake in Getinge | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 56,571 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | -5.07% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 65,201 | 63,219 | 61,157 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | -6.1% | -3.04% | -3.26% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 19.9x | 17x | 15.2x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 1.82x | 1.71x | 1.6x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.8x | 1x | 1.3x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.62x | 1.54x | 1.46x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 1.86x | 1.72x | 1.58x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 9.82x | 8.66x | 7.75x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 13.8x | 12x | 10.6x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.9x | 17.9x | 14.4x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.3% | 5.58% | 6.95% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.053 | 5.543 | 5.896 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.43% | 2.67% | 2.84% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 10.42 | 12.21 | 13.65 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 48.5% | 45.4% | 43.2% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,006 | 36,811 | 38,628 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 6,642 | 7,302 | 7,893 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 4,719 | 5,280 | 5,794 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 2,821 | 3,296 | 3,699 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,630 | 6,648 | 4,585 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 207.70 | 207.70 | 207.70 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 A | 2/1/23 A | 2/1/24 A | 1/28/25 A | 1/27/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.93x | 1.86x | 9.82x | 2.43% | 5.87B | |
| 63.48x | 7.59x | 40.11x | -.--% | 12.51B | |
| 30.38x | 6.28x | 17.06x | 1.24% | 5.87B | |
| 22.87x | 1.15x | 7.14x | -.--% | 4.29B | |
| 28.2x | 8.42x | 21.42x | 0.71% | 4.26B | |
| 16.7x | 2.93x | 14x | 3.91% | 3.83B | |
| -18.8x | 467.88x | -81.24x | -.--% | 1.94B | |
| -10.22x | 2.37x | -10.37x | - | 1.89B | |
| 20.06x | 2.39x | 9.64x | 2.17% | 1.56B | |
| 27.59x | - | - | - | 1.29B | |
| Average | 20.02x | 55.65x | 3.06x | 1.31% | 4.33B | |
| Weighted average by Cap. | 31.93x | 26.43x | 16.02x | 1.07% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- Valuation Getinge AB
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
